Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-010291
Filing Date
2021-02-12
Accepted
2021-02-12 17:33:35
Documents
2
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2214
2 POA DOCUMENT poa.txt EX-24.3_962685 3370
  Complete submission text file 0001209191-21-010291.txt   7052
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Templeman Thomas (Reporting) CIK: 0001654274 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39351 | Film No.: 21630057

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations